{
  "ptid_time": "114_S_0166_2007-02-26",
  "img_path": "/data/qiuhui/data/adni/images/114_S_0166/2007-02-26/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 48,733 mm³, 73.6% above the reference mean. With a Z-score of 1.69 (95.4th percentile), this represents moderate enlargement; hippocampal volume measures 5,443 mm³, 23.5% below the reference mean. With a Z-score of -2.15 (1.6th percentile), this represents significant atrophy; whole brain volume measures 928,844 mm³, 4.7% below the reference mean. With a Z-score of -0.59 (27.7th percentile), this represents normal volume ; entorhinal cortex volume measures 2,954 mm³, 19.6% below the reference mean. With a Z-score of -1.20 (11.5th percentile), this represents mild atrophy; fusiform gyrus volume measures 13,107 mm³, 23.0% below the reference mean. With a Z-score of -2.09 (1.8th percentile), this represents significant atrophy; middle temporal gyrus volume measures 18,570 mm³, 3.1% below the reference mean. With a Z-score of -0.27 (39.3th percentile), this represents normal volume . ",
  "text_data": "Age is 73.5 years. Gender is Female. Education: 18 years. MMSE: 30.0. Logical Memory: 8.0. APOEε4 alleles: 1.0. ",
  "true_diagnosis": "Diagnosis: CN.",
  "gpt_diagnosis": "**Reasoning:** The data shows significant hippocampal and fusiform gyrus atrophy (Z-scores of -2.15 and -2.09, respectively), along with mild entorhinal cortex atrophy, which are hallmark structural changes in Alzheimer's disease. Despite a normal MMSE score (30/30), the presence of these biomarkers suggests early neurodegenerative changes, likely in the preclinical or prodromal stage.  \n\n**Diagnosis:** **MCI** (likely due to Alzheimer's pathology)  \n**Confidence:** **Medium** (high confidence in neurodegeneration, but clinical symptoms are not yet evident, making it uncertain whether this is preclinical AD or early MCI).  \n\n*Note: A normal MMSE in the presence of significant atrophy suggests cognitive reserve or very early disease. Follow-up cognitive testing (e.g., MoCA, episodic memory assessments) and CSF/PET biomarkers could clarify the diagnosis.*",
  "timestamp": "2025-07-26T11:36:59.458539"
}